Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A case of latent tuberculosis reactivation in a patient treated with ustekinumab without concomitant isoniazid chemoprophylaxis in the PEARL trial.

× No keyword cloud information.

11 in total

1. IL12B expression is sustained by a heterogenous population of myeloid lineages during tuberculosis.

Authors: Allison E Reeme; Halli E Miller; Richard T Robinson
Journal: Tuberculosis (Edinb) Date: 2013-03-13 Impact factor: 3.131

Review 2. Unintended Immunological Consequences of Biologic Therapy.

Authors: Sarah E Henrickson; Melanie A Ruffner; Mildred Kwan
Journal: Curr Allergy Asthma Rep Date: 2016-06 Impact factor: 4.806

Review 3. [Nontuberculous mycobacterial infections].

Authors: A Nowag; M Platten; G Plum; P Hartmann
Journal: Z Rheumatol Date: 2017-11 Impact factor: 1.372

Review 4. Novel Therapeutic Approaches to Psoriasis and Risk of Infectious Disease.

Authors: Alfonso Motolese; Manuela Ceccarelli; Laura Macca; Federica Li Pomi; Ylenia Ingrasciotta; Giuseppe Nunnari; Claudio Guarneri
Journal: Biomedicines Date: 2022-01-21

Review 5. Patient considerations and targeted therapies in the management of psoriasis in Chinese patients: role of ustekinumab.

Authors: Yue Zhao; Wei Lai
Journal: Patient Prefer Adherence Date: 2014-06-18 Impact factor: 2.711

Review 6. '"Why me, why now?" Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection.

Authors: M Alexandra Lake; Lyn R Ambrose; Marc C I Lipman; David M Lowe
Journal: BMC Med Date: 2016-03-23 Impact factor: 8.775

7. Serial QuantiFERON-TB Gold testing in patients with psoriasis treated with ustekinumab.

Authors: Chuan-Yu Hsiao; Hsien-Yi Chiu; Ting-Shun Wang; Tsen-Fang Tsai
Journal: PLoS One Date: 2017-09-08 Impact factor: 3.240

8. TNF-α antagonists differentially induce TGF-β1-dependent resuscitation of dormant-like Mycobacterium tuberculosis.

Authors: Ainhoa Arbués; Dominique Brees; Salah-Dine Chibout; Todd Fox; Michael Kammüller; Damien Portevin
Journal: PLoS Pathog Date: 2020-02-18 Impact factor: 6.823

9. The seroconversion rate of QuantiFERON-TB Gold In-Tube test in psoriatic patients receiving secukinumab and ixekizumab, the anti-interleukin-17A monoclonal antibodies.

Authors: Chen-Yu Wu; Hsien-Yi Chiu; Tsen-Fang Tsai
Journal: PLoS One Date: 2019-12-27 Impact factor: 3.240

10. Health Maintenance Consensus for Adults With Inflammatory Bowel Disease.

Authors: Gaurav Syal; Mariastella Serrano; Animesh Jain; Benjamin L Cohen; Florian Rieder; Christian Stone; Bincy Abraham; David Hudesman; Lisa Malter; Robert McCabe; Stefan Holubar; Anita Afzali; Adam S Cheifetz; Jill K J Gaidos; Alan C Moss
Journal: Inflamm Bowel Dis Date: 2021-10-18 Impact factor: 5.325